12:14 AM EDT, 10/19/2026 (MT Newswires) -- GenSight Biologics (SIGHT.PA) raised 1 million euros through an offering of shares and warrants to existing shareholders, according to an Oct. 16 release. The French biopharma company issued 2,597,404 ordinary shares, 11,940,300 pre-funded warrants, and 14,537,704 warrants as part of the offering.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.